Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-06-27 00:00:00 ET · period of report 2024-06-26 · accession 0001510281-24-000343 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-06-27 | 2024-06-26 | HQL | Weinstein Boaz | 10% | P - Purchase | $14.07 | +100 | 3.43M | +0.0% | +$1,407 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-26 | P | A | 100 | $14.07 | 3,429,991 | I - | — | — |